Target intelligence / Profile preview

Salsola kali pollen allergen (Sal k 1) (Sal k 1)

Target
Sal k 1
Molecular classification
Pectin methylesterase, Kinase, Cobalamin-independent methionine synthase, Profilin, Ole e 1-like protein, Allergen
01

Overview

Salsola kali, commonly known as Russian thistle or tumbleweed, is a significant source of aeroallergens in arid and semi-arid regions, including the Middle East and the Southwestern United States (Assarehzadegan et al., 2009). The pollen contains several allergenic proteins, with Sal k 1, a pectin methylesterase, being the most clinically relevant major allergen responsible for sensitization in the majority of affected patients (UniProt P84358; Gadermaier et al., 2004). These proteins trigger Type I hypersensitivity reactions in sensitized individuals, leading to symptoms of allergic rhinitis, conjunctivitis, and bronchial asthma (Bousquet et al., 2001). In the context of drug development and therapy, these allergens are the primary components of allergen-specific immunotherapy (AIT) extracts. AIT aims to desensitize patients by administering gradually increasing doses of the allergen to induce immunological tolerance (Akdis & Akdis, 2014). Understanding the molecular structure of Sal k 1 and its isoforms is crucial for improving the standardization of diagnostic tests and the efficacy of therapeutic vaccines.

Other names
Russian thistle pollen allergenTumbleweed pollen allergenSal k 1Sal k 2Sal k 3Sal k 4Sal k 5Pectin methylesterase Sal k 1
02

Mechanism of action

Allergen-specific immunotherapy (AIT) utilizes the allergen to induce immunological tolerance by shifting the immune response from a Th2-dominated profile to a Th1/Treg profile, increasing the production of IL-10 and TGF-beta, and stimulating the production of allergen-specific IgG4 antibodies that compete with IgE for allergen binding (Akdis & Akdis, 2014; Moingeon, 2013).

03

Biological functions

Immune responsePollen tube growthCell wall modificationMethionine biosynthesis
04

Disease associations

Allergic rhinitisAsthmaConjunctivitisType I hypersensitivity
05

Safety considerations

Risk of anaphylaxisSystemic allergic reactionsLocal injection site reactionsCross-reactivity with other Amaranthaceae/Chenopodiaceae species
06

Interacting drugs

Salsola kali pollen extract

4 more in the full profile.

07

Biomarkers

Specific IgE (sIgE) to Sal k 1Skin prick test (SPT) reactivitySpecific IgG4 levels

Beyond the preview

Go deeper on Salsola kali pollen allergen (Sal k 1) (Sal k 1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salsola kali pollen allergen (Sal k 1) (Sal k 1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call